167 results on '"Aceto, Mario D."'
Search Results
2. Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1 R,5 R,9 R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)
3. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice
4. l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice
5. NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action
6. Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1R,5R,9R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)
7. Effects of JDTic, a selective κ-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model
8. BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism
9. Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist
10. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist
11. Discriminative Stimulus, Reinforcing, Physical Dependence, and Antinociceptive Effects of Oxycodone in Mice, Rats, and Rhesus Monkeys
12. The effects of Δ9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors
13. N-(Trifluoromethyl)benzyl substituted N-Normetazocines and N-Norketobemidones
14. Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2
15. Discriminative stimulus properties of the optical isomers of nicotine
16. Differences in antiwrithing activity of morphine and nalorphine over time and in slopes of the dose-response lines
17. The effects of certain psychotropic agents on the conditioned emotional response behavior pattern of the albino rat
18. Effects of reserpine and chlorpromazine on rats subjected to experimental stress
19. COMPARATIVE STUDY OF THE EFFECTS OF TWO NARCOTIC ANTAGONISTS NALOXONE AND NALORPHINE ON DEVELOPING MORPHINE DEPENDENCE IN RHESUS MONKEY
20. ANALGESIC AND PHYSICAL DEPENDENCE LIABILITY OF TWO NEW ESTERS OF N-METHYLPIPERIDINE
21. Exploring Pharmacological Activities and Signaling of Morphinans Substituted in Position 6 as Potent Agonists Interacting with the μ Opioid Receptor
22. Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
23. MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
24. Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities
25. Mixed κ/μ Opioid Receptor Agonists: The 6β-Naltrexamines
26. Cinnamoyl Derivatives of 7α-Aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7α-Aminomethyl-6,14-endo-ethanotetrahydrooripavine and Related Opioid Ligands
27. Probes for Narcotic Receptor Mediated Phenomena. 34. Synthesis and Structure−Activity Relationships of a Potent μ-Agonist δ-Antagonist and an Exceedingly Potent Antinociceptive in the Enantiomeric C9-Substituted 5-(3-Hydroxyphenyl)-N-phenylethylmorphan Series
28. Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a µ-agonist δ-antagonist and δ-inverse agonists
29. Effect of a 6-Cyano Substituent in 14-Oxygenated N-Methylmorphinans on Opioid Receptor Binding and Antinociceptive Potency
30. Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 21. Novel 4-Alkoxy and 14-Phenylpropoxy Derivatives of the μ Opioid Receptor Antagonist Cyprodime
31. Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 20. 14-Phenylpropoxymetopon: An Extremely Powerful Analgesic
32. 4‘-Arylpyrrolomorphinans: Effect of a Pyrrolo-N-benzyl Substituent in Enhancing δ-Opioid Antagonist Activity
33. Drugs and avoidance performance
34. Similarities in effects of barbiturates and mild tranquilizers on activity in mice
35. Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2‘-hydroxy-6,7-benzomorphan Homologues
36. Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat
37. N-cyclohexylethyl-N-noroxymorphindole: a μ-Opioid preferring analogue of naltrindole
38. Stereoselective μ- and δ-opioid receptor-related antinociception and binding with (+)-thebaine
39. 3-Alkyl Ethers of Clocinnamox: Delayed Long-Term μ-Antagonists with Variable μ Efficacy
40. Etorphines: μ-opioid receptor-selective antinociception and low physical dependence capacity
41. Cocaine, Ecgonine Methyl Ester, and Benzoylecgonine Plasma Profiles in Rhesus Monkeys
42. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
43. Antipodal .alpha.-N-(Methyl through Decyl)-N-normetazocines (5,9.alpha.-Dimethyl-2'-hydroxy-6,7-benzomorphans): In vitro and In vivo Properties
44. Common stereospecificity of opioid and dopamine systems for N-butyrophenone prodine-like compounds
45. Central actions of nicotine.
46. The Antinicotinic Effects of Drugs with Clinically Useful Sedative-Antianxiety Properties.
47. THE CORONARY VASODILATORY EFFECTS OF 2-AMINOETHYL-NITRATE p-TOLUENESULFONATE.
48. THE EFFECTS OF ISOSORBIDE DINITRATE ON CORONARY VASCULAR RESISTANCE.
49. 2,5-Dimethyl-2′-hydroxy-9α- and 9β-(3-Methylbutyl)-6,7-benzomorphans and N-Substituted Compounds in the 9α-(3-Methylbutyl) Series: Chemistry, Pharmacology, and Biochemistry
50. Potential Long Acting Opiate Antagonists: Preparation, Pharmacological Activity, and Opiate-Receptor Binding of N-Substituted 2′-Hydroxy-5-methyl-9α-propyl-6,7-benzomorphans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.